Brown CardioPulmonary Research Training Program

描述(由申请者提供)：布朗心肺培训计划的总体目标是培训医生和科学家，他们将成为心血管和肺部疾病的分子基础和病理生物学以及这些疾病的预防和治疗结果的独立研究人员。这将通过严格的教学培训计划和在合作、多学科环境下的指导研究经验和职业发展培训来实现。四名拥有医学博士、博士或医学博士/博士学位的博士后实习生每年将被录取参加为期3年的研究培训计划。来自11个学术部门的33名经验丰富且资金雄厚的教员培训师加上7名有前途的初级教员培训师制定了一个培训计划，利用7家布朗教学医院和布朗大学的资源。该培训计划旨在弥合生物医学、行为和公共卫生学科之间的差距，以促进关于如何最好地减少患有影响心血管系统和肺部疾病的患者的疾病负担的知识。这将通过心血管和肺部疾病的分子病理生物学或卫生服务/结果方面的培训来实现。这一培训计划的独特之处在于，在涉及这些系统的疾病(如衰老)的相关研究中，培训个人。让受训者从工作台到床边再到实践方面研究这些问题，可以带来新的见解、协同研究路线和使用分子方法以及流行病学、临床试验和卫生服务调查的科学进步。(摘要结束)

DESCRIPTION (provided by applicant): The Brown CardioPulmonary Training Program has as its overall objective the training of physicians and scientists who will become independent investigators in the molecular basis and pathobiology of cardiovascular and pulmonary diseases and the outcomes of prevention and treatment of these diseases. This will be accomplished by a rigorous program of didactic training and mentored research experience in a collaborative, multidisciplinary setting with career development training. Four postdoctoral trainees with an MD, PhD, or MD/PhD degree will be accepted per year into a 3- year research training program. Thirty-three experienced and well-funded faculty trainers plus seven promising junior faculty trainers from 11 academic departments have developed a Training Program that utilizes resources from 7 Brown teaching hospitals plus Brown University. The Training Program aims to bridge gaps between bio-medical, behavioral and public health disciplines to advance knowledge regarding how best to reduce disease burden among patients with diseases that affect the cardiovascular system and lungs. This will be accomplished by training in Molecular Pathobiology of Cardiovascular and Pulmonary Diseases or in Health Services/Outcomes. This Training Program is uniquely positioned to train individuals in research related to diseases that involve these systems, such as aging. Having trainees looking at these problems from both bench to bedside and bedside to practice aspects can lead to new insights, lines of synergistic research and advances in science using both molecular methods and epidemiologic, clinical trials, and health services investigations. (End of Abstract)